Quattro Financial Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-15,000
Closed -$380K – 92
2022
Q3
$380K Sell
15,000
-326
-2% -$11.4K 0.15% 65
2022
Q2
$509K Hold
15,326
– – 0.17% 59
2022
Q1
$1.1M Buy
+15,326
New +$1.1M 0.37% 45
2021
Q4
– Sell
-1,600
Closed -$226K – 116
2021
Q3
$226K Sell
1,600
-4,898
-75% -$713K 0.06% 91
2021
Q2
$939K Sell
6,498
-2,255
-26% -$365K 0.25% 64
2021
Q1
$1.6M Buy
8,753
+382
+5% +$88.6K 0.36% 54
2020
Q4
$1.9M Buy
+8,371
New +$1.7M 0.5% 31
2019
Q3
– Sell
-5,500
Closed -$377K – 84
2019
Q2
$377K Buy
+5,500
New +$321K 0.12% 42

Other funds holding TDOC

Quattro Financial Advisors's TDOC Position: Q4 2022 in Review

Quattro Financial Advisors sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 15,000 shares — an estimated $380K sold.

Quattro Financial Advisors first reported a position in TDOC in Q2 2019 and held it in 8 quarters. The position peaked at $1.9M in Q4 2020. 443 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • Quattro Financial Advisors reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
  • Quattro Financial Advisors sold 15,000 Teladoc Health shares in Q4 2022, an estimated $380K.
  • Quattro Financial Advisors first reported a position in Teladoc Health in Q2 2019 and held it in 8 quarters.
  • Quattro Financial Advisors's Teladoc Health position peaked at $1.9M in Q4 2020.
  • 443 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on Quattro Financial Advisors's 13F filing for Q4 2022, filed 23 Jan 2023.